Galectin Therapeutics | GALT - 전 세금 이익





전 세금 이익 변화 날짜
AbbVie USD 7.61B 2.04B 2026-06
Bristol-Myers Squibb USD 4.99B 1.75B 2026-06
Galectin Therapeutics USD -12.37M 880K 2024-06
Gilead Sciences USD 2.08B 1.56B 2025-12
Immunic USD -19.3M 6.28M 2025-12
Incyte USD 751.51M 407.91M 2026-06
Merck USD 3.42B 3.32B 2025-12